Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
<img src="http://feeds.foxbusiness.com/~r/foxbusiness/latest/~4/278350286" height="1" width="1"/><img src="http://feeds.foxnews.com/~r/foxnews/business/~4/278357690" height="1" width="1"/>
http://feeds.foxnews.com/~r/foxnews/business/~3/278357690/